Andere Sprachen Vivos Inc.

Aktien

A2PM7K

US92858K2042

RDGL

Markt geschlossen - OTC Markets Andere Börsenplätze 21:59:59 17.05.2024			% 5 Tage	% 1. Jan.
0,1785 ^USD	-3,04 %		-10,75 %	+146,89 %

09.05.	Vivos Inc. meldet Ergebnis für das erste Quartal bis zum 31. März 2024	CI
18.03.	Vivos Inc. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Vivos Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09.05.
Vivos Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	18.03.
Radiogel™ Precision Radionuclide Therapy™ Receives FDA Breakthrough Device Designation	20.12.
Vivos Inc. Announces Radiogel(TM) Precision Radionuclide Therapy(TM) Receives FDA Breakthrough Device Designation	20.12.
Vivos Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	06.11.
Vivos : Quarterly Progress Report - Form 8-K	11.10.23
Vivos Inc. Announces Certification of Three New IsoPet® Precision Radionuclide Therapy Regional Clinics	07.08.23
Vivos Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	04.08.23
VIVOS INC Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	04.05.23
Vivos Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	04.05.23
VIVOS INC : Unregistered Sale of Equity Securities (form 8-K)	02.05.23
VIVOS INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-K)	01.03.23
Vivos Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	01.03.23
Vivos Inc. Auditor Raises 'Going Concern' Doubt	01.03.23
Vivos Inc Files a New Patent on Alternate Particles for Precision Radionuclide Therapy	11.01.23
Vivos Inc Files A New Patent on Alternate Particles for Precision Radionuclide Therapy	11.01.23
Vivos Inc Files a New Patent on Precision Radionuclide Therapy Support System Equipment	03.01.23
Vivos Inc. Files New Patent on Precision Radionuclide Therapy Support System Equipment	03.01.23
VIVOS INC Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	19.10.22
Vivos Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	19.10.22

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Vivos Inc.

Aktien

A2PM7K

US92858K2042

RDGL

Andere Sprachen

Filter